The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 123 results:
Author [ Title(Desc)] Type Year
Filters: Author is Tsapas, Apostolos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Sarigianni, M., Liakos A., Vlachaki E., Paschos P., Athanasiadou E., Montori V. M., et al. (2015).  Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis.. Clin Gastroenterol Hepatol. 13(1), 55-63.e5.
Tsapas, A. (2009).  ACP Journal Club. Intensive insulin therapy reduced long-term risk for incident hypertension in type 1 diabetes.. Ann Intern Med. 150(4), JC2-12.
Paschos, P., Ioakim K., Malandris K., Koukoufiki A., Nayfeh T., Akriviadis E., et al. (2021).  Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.. Anaerobe. 71, 102441.
Rizava, C., Bekiari E., Liakos A., Sarigianni M., Rika M., Haidich A. Bettina, et al. (2016).  Antigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis. Endocrine. 541493253564319603435853315343646323232332378366375452107937693091093863(331029229844492951104144411978855372514249), 620 - 633.
Bekiari, E., Kitsios K., Thabit H., Tauschmann M., Athanasiadou E., Karagiannis T., et al. (2018).  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. k1310.
Bekiari, E., Kitsios K., Thabit H., Tauschmann M., Athanasiadou E., Karagiannis T., et al. (2018).  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.. BMJ. 361, k1310.
Mainou, M., Madenidou A-V., Liakos A., Paschos P., Karagiannis T., Bekiari E., et al. (2017).  Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis. European Journal of Haematology. 98111125151171328622526459851317339343312102118301141312212432349259292117201512520158233100(6), 563 - 568.
Mainou, M., Madenidou A-V., Liakos A., Paschos P., Karagiannis T., Bekiari E., et al. (2017).  Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis.. Eur J Haematol. 98(6), 563-568.
B
Montori, V. M., LeBlanc A., Buchholz A., Stilwell D. L., & Tsapas A. (2013).  Basing information on comprehensive, critically appraised, and up-to-date syntheses of the scientific evidence: a quality dimension of the International Patient Decision Aid Standards.. BMC Med Inform Decis Mak. 13 Suppl 2, S5.
Liakos, A., Karagiannis T., Avgerinos I., Tsapas A., & Bekiari E. (2023).  Burden and Coping Strategies of Hypoglycemia in People with Diabetes.. Curr Diabetes Rev.
C
Karagiannis, T., Bekiari E., & Tsapas A. (2017).  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy. Core Evidence. Volume 12, 1 - 10.
Karagiannis, T., Bekiari E., & Tsapas A. (2017).  Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.. Core Evid. 12, 1-10.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications. Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.. Ther Adv Drug Saf. 7(2), 36-8.
Rouskas, K., Kouvatsi A., Paletas K., Papazoglou D., Tsapas A., Lobbens S., et al. (2012).  Common variants in FTO, MC4R, TMEM18, PRL, AIF1, and PCSK1 show evidence of association with adult obesity in the Greek population.. Obesity (Silver Spring). 20(2), 389-95.
Tsapas, A., Karagiannis T., Avgerinos I., Matthews D. R., & Bekiari E. (2021).  Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.. Ann Intern Med. 174(1), 141.
Tsapas, A., Avgerinos I., Karagiannis T., Malandris K., Manolopoulos A., Andreadis P., et al. (2020).  Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.. Ann Intern Med. 173(4), 278-286.
Avgerinos, I., Manolopoulos A., Michailidis T., Kitsios K., Liakos A., Karagiannis T., et al. (2021).  Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(3), 822-831.
Malandris, K., Papandreou S., Avgerinos I., Karagiannis T., Paschos P., Michailidis T., et al. (2023).  Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis.. Hormones (Athens). 22(4), 655-664.
Tsapas, A., Karagiannis T., Kakotrichi P., Avgerinos I., Mantsiou C., Tousinas G., et al. (2021).  Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(9), 2116-2124.
Gourzoulidis, G., Tzanetakos C., Ioannidis I., Tsapas A., Kourlaba G., Papageorgiou G., et al. (2018).  Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece. Clinical Drug Investigation. 3831184061314132015410373121437191919154637191436(511Suppl 2518942221193773988), 417 - 426.
Gourzoulidis, G., Tzanetakos C., Ioannidis I., Tsapas A., Kourlaba G., Papageorgiou G., et al. (2018).  Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.. Clin Drug Investig. 38(5), 417-426.
Liakos, A., Liakopoulou P., & Tsapas A. (2020).  Cyclical pressurized topical wound oxygen therapy increased healing of refractory diabetic foot ulcers.. Ann Intern Med. 172(6), JC27.
D
Papadopoulou, E., Loutradis C., Tzatzagou G., Kotsa K., Zografou I., Minopoulou I., et al. (2020).  Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.. J Hypertens.
Papadopoulou, E., Theodorakopoulou M. P., Loutradis C., Tzanis G., Tzatzagou G., Kotsa K., et al. (2021).  Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus.. Am J Hypertens. 34(4), 404-413.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.